This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Develco Pharma Schweiz Ag, Kremers Urban Pharmaceuticals, Inc`. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Dirk Kramer: Innovator in Pharmaceutical Formulations
Introduction
Dirk Kramer is a notable inventor based in Herznach, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of controlled-release oral dosage forms.
Latest Patents
Dirk Kramer holds two patents that showcase his innovative work. His first patent is for a controlled-release oral dosage form comprising oxycodone. This invention relates to a method of preparing a controlled-release oral dosage form for the administration of oxycodone once a day. His second patent involves a pharmaceutical dosage form that pertains to an oral pharmaceutical formulation for methylphenidate or its analogs, derivatives, isomers, or enantiomers, including d-threo-methylphenidate.
Career Highlights
Throughout his career, Dirk has worked with reputable companies in the pharmaceutical industry. He has been associated with Develco Pharma Schweiz AG and Kremers Urban Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Dirk has collaborated with several professionals in his field, including Mathias Scheer and Hélène Rey. These collaborations have likely enhanced his research and development efforts in pharmaceutical formulations.
Conclusion
Dirk Kramer is a distinguished inventor whose work in controlled-release oral dosage forms has made a significant impact in the pharmaceutical industry. His patents reflect his commitment to advancing medication delivery systems.